share_log

EF Hutton Maintains Hold on Rain Oncology, Lowers Price Target to $2

Benzinga ·  May 30, 2023 10:47

EF Hutton analyst Tony Butler maintains Rain Oncology (NASDAQ:RAIN) with a Hold and lowers the price target from $5 to $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment